Ph.D. Paul A. Wagner - 07 Sep 2021 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
CEO, President, Secretary and Chair of the Board, Director
Signature
/s/ Antony Riley, as Attorney-in-Fact
Issuer symbol
FBRX
Transactions as of
07 Sep 2021
Net transactions value
-$4,347,100
Form type
4
Filing time
08 Sep 2021, 17:02:40 UTC
Next filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBRX Common Stock Sale $4,347,100 -1,000,000 -44% $4.35 1,279,049 07 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 1,000,000 shares sold in the price range of $4.1403 to $4.64 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Remarks:

CEO, President, Secretary and Chair of the Board